You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Your Nucala treatment

This page is specifically for patients who have been prescribed Nucala. If you are not a patient who has already been prescribed Nucala, please return to the public website.

Why have I been prescribed this medication?

NUCALA is a treatment option for people who have severe refractory eosinophilic asthma. The decision to prescribe you this medication was based on an assessment of:


You current asthma symptoms, including the number of asthma attacks.


The types of medications you take.

test tube

Routine blood tests.

Should I continue my existing medication

  • Yes. Nucala is an add-on treatment, which means you should continue to take your other medications as prescribed by your doctor. 
  • It is recommended that all patients with asthma have an asthma action plan. 
  • If you have any questions, please ask your doctor or nurse at your next appointment.

How will I know if Nucala is working for me?

  • All asthma patients should have an asthma action plan. Download your asthma action plan here and fill it in with your doctor or nurse:
  • Keep a written record of your progress to share with your doctor.

Nucala is a registered trademark of the GlaxoSmithKline group of companies

Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.